SAN DIEGO, Calif. – September 29, 2003 – Pharmatek Laboratories, Inc. today announced the opening of a new pharmaceutical chemistry development laboratory located in the heart of San Diego’s BioPharma region. This is the third move in 5 years for the fast growing provider of pharmaceutical chemistry development services. The facility includes 10,888 square feet of space including formulation, analytical and dissolution laboratories, ICH stability storage, office space and two newly built GMP manufacturing suites.
“Our focus has always been to get our clients’ molecules from discovery into the clinic as efficiently as possible. This facility allows us to bring more process controls, better QA systems, and superior formulation and manufacturing facilities to our clients’ pharmaceutical products,” said Jeffrey A. Bibbs, Ph.D., Pharmatek’s Chief Executive Officer. “In particular, this allows us to significantly increase our formulation development, GMP manufacturing and stability storage capabilities.”
The new facility is more than triple the size of Pharmatek’s previous laboratory space and has been designed to support the companies’ growth in drug development services and also provide room for additional expansion. The new facility build-out includes expanded analytical and formulation development laboratories, increased capacity for ICH stability storage and testing, registered GMP manufacturing suites and CTM storage.
As large pharmaceutical companies, generic drug manufacturers and biotech start-ups outsource development work at an increasing rate, Pharmatek is positioning itself to support these companies to manage internal resource constraints, solve unique formulation challenges and exploit the full potential of their product pipelines.Leave a reply →